@StonkMaster
The question then is what timing is most advantageous for the company, if SP/market reaction is any immediate concern to them — AU or US investor attention?
Would have helped local investor nerves today, which makes its absence really interesting. (Past announcement timing doesn't give any clues — the trend has been a.m. announcements here, except for appointment of a chief operating officer which was p.m.).
Ulcerative Colitis Clinical Trial, page-7
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.020(1.78%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.11 | $2.048M | 1.820M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3195 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 73678 | 22 |
View Market Depth
| Last trade - 10.43am 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |